Literature DB >> 6997906

Radioimmunological assay of prostacyclin synthetase activity.

C L Tai, H H Tai.   

Abstract

A radioimmunoassay for 6-oxoprostaglandin F1 alpha has been developed. 6-Oxoprostaglandin F1 alpha antiplasma was produced in rabbits by repeated immunization with 6-oxoprostaglandin F1 alpha coupled to bovine serum albumin. [125I] -labelled hapten with high specific radioactivity was prepared by radioiodination of 6-oxoprostaglandin F1 alpha-tyrosine methyl ester conjugate followed by purification with thin layer chromatography. The antibodies showed good specificity toward 6-oxoprostaglandin F1 alpha and crossreacted only significantly with prostaglandin F1 alpha. The radioimmunoassay was applied to the determination of prostacyclin synthetase activity in swine aorta microsomes using arachidonic acid and prostaglandin H2 as indirect and direct substrates. The enzyme assay was validated by the criteria that the formation of 6-oxoprostaglandin F1 alpha, immunoreactivity from either substrates was both time and enzyme protein dependent, and was inhibitable by specific inhibitors of the enzyme system.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997906     DOI: 10.1016/0161-4630(80)90048-8

Source DB:  PubMed          Journal:  Prostaglandins Med        ISSN: 0161-4630


  3 in total

1.  Characterization of heme environment and mechanism of peroxide bond cleavage in human prostacyclin synthase.

Authors:  Hui-Chun Yeh; Pei-Yung Hsu; Jinn-Shyan Wang; Ah-Lim Tsai; Lee-Ho Wang
Journal:  Biochim Biophys Acta       Date:  2005-12-20

2.  Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.

Authors:  Yi-Ching Li; Chia-Wang Chiang; Hui-Chun Yeh; Pei-Yung Hsu; Frank G Whitby; Lee-Ho Wang; Nei-Li Chan
Journal:  J Biol Chem       Date:  2007-11-21       Impact factor: 5.157

3.  Dissociation of systemic and renal effects in endotoxemia. Prostaglandin inhibition uncovers an important role of renal nerves.

Authors:  W L Henrich; Y Hamasaki; S I Said; W B Campbell; R E Cronin
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.